P-Xylene

P-Xylene

SCHEMBL235090

COCCOC.Cc1ccc(C)cc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.53
TDP1 Q9NUW8 2/20 0.53
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
AGXT P21549 2/20 0.42
TSHR P16473 2/20 0.42
CYP3A4 P08684 1/20 0.42
IDO1 P14902 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL4761329 0.85 TSHR (0.61) ACHEHPGDLMNATSHRCA2
SCHEMBL6445608 0.84 DRD2 (0.55) ACHEHPGDDRD2DRD4DRD3
P-Xylene SCHEMBL3688331 0.83 GAA (0.43) ACHETDP1ALDH1A1HPGDLMNA
P-Xylene SCHEMBL8994094 0.81 GAA (0.41) ACHETDP1ALDH1A1HPGDLMNA
SCHEMBL2612033 0.81 CYP1A2 (0.52) ACHETDP1AGXTIDO1DRD2
SCHEMBL7606495 0.81 AGXT (0.50) TDP1ALDH1A1AGXTIDO1CA1
P-Xylene SCHEMBL15876027 0.80 ACHE (0.53) ACHETDP1ALDH1A1LMNAAGXT
SCHEMBL13645868 0.79 DRD2 (0.46) ACHELMNATSHRDRD2DRD4
SCHEMBL14926657 0.79 DRD2 (0.50) ACHEALDH1A1HPGDLMNAHTT
SCHEMBL12835053 0.79 KDM4E (0.54) ACHEALDH1A1HPGDLMNADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12312300-B2 Process for recovering close boiling products LANZATECH, INC. (US) 2025-05-27 US claimed
EP-4416297-A1 FLEXIBLE PRODUCT SEPARATION AND RECOVERY Lanzatech, Inc. (US) 2024-08-21 EP claimed
US-20240059628-A1 PROCESS FOR RECOVERING CLOSE BOILING PRODUCTS LANZATECH, INC. 2024-02-22 US claimed
WO-2023064695-A1 FLEXIBLE PRODUCT SEPARATION AND RECOVERY LANZATECH, INC. (US) 2023-04-20 WO claimed
US-20230113411-A1 FLEXIBLE PRODUCT SEPARATION AND RECOVERY LANZATECH, INC. 2023-04-13 US claimed
EP-3921433-A1 PROCESS FOR RECOVERING CLOSE BOILING PRODUCTS Lanzatech, Inc. (US) 2021-12-15 EP claimed
US-11091415-B2 Process for recovering close boiling products LANZATECH, INC. (US) 2021-08-17 US claimed
CN-112969795-A Process for recovering close boiling products 朗泽科技有限公司 2021-06-15 CN claimed
US-10927270-B2 Oil-based ink composition for writing instruments, and writing instrument, marking pen and ballpoint pen comprising the same KABUSHIKI KAISHA PILOT CORPORATION (JP) 2021-02-23 US claimed
US-20200255362-A1 PROCESS FOR RECOVERING CLOSE BOILING PRODUCTS LANZATECH PRIVATE LIMITED 2020-08-13 US claimed
WO-2020163020-A1 PROCESS FOR RECOVERING CLOSE BOILING PRODUCTS LANZATECH, INC. (US) 2020-08-13 WO claimed
US-5445716-A With stable and reusable extractive agent which improves relative volatility difference Berg, Lloyd (US) 1995-08-29 US claimed
JP-9176263-A None JP disclosed
JP-8239559-A None JP disclosed
US-12312300-B2 Process for recovering close boiling products LANZATECH, INC. (US) 2025-05-27 US disclosed
EP-4416297-A1 FLEXIBLE PRODUCT SEPARATION AND RECOVERY Lanzatech, Inc. (US) 2024-08-21 EP disclosed
EP-0838537-A1 METAL SURFACE TREATMENTS, METHOD FOR TREATING METAL SURFACE, AND SURFACE-TREATED METALLIC MATERIAL NIPPON PAINT CO., LTD. (JP) 1998-04-29 EP disclosed
JP-H09176263-A PHENOLIC RESIN COMPOSITION SUMITOMO DUREZ CO LTD 1997-07-08 JP disclosed
JP-H08239559-A RESIN COMPOSITION FOR FRICTION MATERIAL SUMITOMO DUREZ CO LTD 1996-09-17 JP disclosed
US-5445716-A With stable and reusable extractive agent which improves relative volatility difference Berg, Lloyd (US) 1995-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10927270-B2 Oil-based ink composition for writing instruments, and writing instrument, marking pen and ballpoint pen comprising the same MKI67, JAK2, BRPF3 ACHE 3160/4885TDP1 1682/4885ALDH1A1 696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.